Context: Survival rates after severe injury are improving, but complication rates and outcomes are variable. 36
INTRODUCTION 59
Over 5 million people worldwide die each year from serious injury (1), with almost 25% caused by road 60 traffic collisions (RTC) (2) . In England alone, there are 5400 trauma deaths and 20,000 severe injuries treated by 61 the National Health Service annually (3) . Since 2012, the establishment of 22 trauma centres in England has been 62 accompanied by a 19% improvement in survival odds following injury (4) . During this time, the UK also received 63 severely injured military trauma patients from the conflict in Afghanistan (5, 6) . 64 Improvements in short-term outcomes have been achieved through early resuscitation and acute care (7) , 65 often informed by approaches pioneered on the battlefield. However, improvement in survival is often offset 66 during the weeks following acute major trauma by the systemic inflammatory response syndrome (SIRS), which 67 is associated with increased risks of infection, multi-organ dysfunction or failure (MOD/MOF), and death (8, 9) .
68
Simultaneously, the hypothalamic-pituitary-adrenal axis (HPA) is thought to drive a hypermetabolic and overtly 69 catabolic response. Importantly, in this profound catabolic state, patients lose valuable lean muscle and suffer from 70 increased rates of infection and poor wound healing. Moreover, the dynamic nature of this response, especially 71 beyond the first few days following injury and during recovery remains poorly described and understood, limiting 72 the evidence base for novel therapeutic interventions. Burn injury also produces an extreme inflammatory and 73 catabolic response after injury, previously targeted by anabolic steroid analogues (10) and beta-blockade (11) .
74
The dynamic changes in endogenous glucocorticoids and their influence on adrenal steroid metabolism after severe 75 injury are not well characterized. We know that pro-inflammatory cytokines activate the enzyme 11β-76 hydroxysteroid dehydrogenase type (11β-HSD1) responsible for tissue-specific activation of glucocorticoids 77 through conversion of inactive cortisone to active cortisol (12) . However, only scarce data exist on what happens 78 to early sex steroids and their precursors during this catabolic state. 79
To address these gaps in knowledge, we have undertaken a detailed prospective study of the endocrine 80 and metabolic response to severe injury in military and civilian populations, recruiting patients within 24 hours of 81 major trauma and following up for the six months post-trauma. This was undertaken to identify predictive 82 biomarkers and therapeutic targets as well as to explore the optimal timing for therapeutic interventions that could 83 promote better recovery after severe traumatic injury. 84
MATERIALS AND METHODS 85

Study Design and Protocol 86
This prospective cohort study was conducted in the Royal Centre for Defense Medicine and the Queen 87
Elizabeth Hospital Birmingham, a major UK trauma centre and the primary receiving facility for UK military 88 personnel injured abroad. Military and civilian trauma patients with an estimated New Injury Severity Score 89 (NISS) >15 were recruited (13) . NISS was used to ensure those with significant extremity trauma but lower ISS 90 were included (14) . Patients with significant head injury or pre-injury neoplastic conditions were not eligible.
91
None of the patients received etomidate during their treatment. Informed consent was obtained from personal 92 consultees until recovering capacity. The protocol was approved by the NRES Committee South West -Frenchay 93 11/SW/0177 and MOD REC 116/Gen/10. 94
A daily patient review allowed the injured to be clinically phenotyped. Bespoke study management 95 software (Clinical RESearch Tool -CREST) tracked the patient and their clinical data were entered prospectively 96 and used to calculate Acute Physiology and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure 97 Assessment (SOFA), and Simplified Acute Physiology Score (SAPS) (15, 16) . Sepsis was defined using Bone's 98 criteria of an infection associated with SIRS (17) , current at the time of the study. 99
Details of opioid administration were collected from the electronic health record and prescribing system 100 (PICS) (18) on each of the study patients. The total amount of opioid given during their hospital stay was 101 appropriately weighted and totalled with equivalence to an oral dose of 10mg morphine, adjusting for potency, 102 delivery method and opioid preparation (19) . 103
Blood and urine samples were collected within 24 hours of acute injury and at 3, 5, 10, 14, 21, 28 days 104 and 2, 3, 4 and 6 months during recovery post-trauma. Blood sampling occurred between 0730 and 0900 hrs; 105 serum was then separated and frozen at -80 o C for batched analysis. We separately collected morning blood 106 samples from 37 healthy age-and sex-matched controls, to provide a comparator for the steroid data. 107 6
Assessment of Protein Catabolism 108
As a surrogate marker for muscle mass, we undertook longitudinal measurements of muscle thickness by 109 a well validated method using portable ultrasound as described by Campbell et al. (20, 21) . Ultrasound 110 measurements were taken from four different muscle sites (biceps brachii, radial forearm, rectus femoris and rectus 111 abdominis) at weekly intervals while in hospital and at 3, 4, 5 and 6 months following discharge. All ultrasound 112 assessments were performed by two trained operators. Measurements were performed three times at each muscle 113 site and the mean of the three measurements was recorded. The dominant arm was favoured for ultrasound 114 assessment of muscle mass unless it was missing or unable to be measured where wounds were extensive. This 115 non-invasive method was chosen over others such as creatine (methyl-d3) dilution (D3-creatine) (22) due to the 116 strict dietary requirements for methy-d3 estimation, which was not practical in the context of major trauma. 117
Similarly, we did not undertake MRI measurement of muscle mass due to the risk associated with repeated 118 transport of critically ill patients to scanning facilities (23). 119
Urinary urea excretion was measured and used to estimate Total Urinary Nitrogen (TUN) excretion as 120 described by Milner et al. (24) [Estimated Nitrogen Excretion: Urinary Urea Excretion (mmol/l) x 0.028 x 1.25 = 121
Total Urinary Nitrogen excretion (g/l)]. 122
Steroid Analysis 123
Serum concentrations of adrenal and gonadal steroids were measured using liquid chromatography-124 tandem mass spectrometry (LC-MS/MS) analysis, employing a validated multi-steroid profiling method (25). In (SIM) mode, as previously described (30).
7
Serum concentrations of sex hormone-binding globulin (SHBG) and luteinizing hormone (LH) were 132 analysed on the Roche Modular System (Roche Diagnostics, Lewes, UK) by two-site sandwich immunoassay 133 using electrochemiluminesence technology. 134
Statistical Analysis 135
The raw data were evaluated by analysis of variance (ANOVA). In addition, paired and unpaired Student's 136 t-test, Chi-Square Analysis and Mann-Whitney tests were used where appropriate. 137
Generalized linear mixed-effects models (31) were used to examine the change in variables over time.
138
Patients were included in models as random effects to account for repeat measures over time on the same 139 individuals. Time was modelled using restricted cubic splines (32) to allow for flexible relationships (33).
140
Severity scores were modelled as Poisson distributions due to their skewness and non-negative ranges. Plots of 141 predicted average fixed effects with 95% confidence intervals were produced for the first four weeks and first six 142 months post-injury as required. Analyses were conducted in R using libraries lme4, effects, rms and ggplot2. 143
RESULTS 144
Patient Recruitment and Clinical Characteristics of the Final Study Cohort 145
We screened 996 multiply injured adults. The majority of the 889 excluded patients had a NISS≤15, 146 others had a significant head injury as their major injury component, and two were excluded due to a pre-injury 147 diagnosis of cancer. Of the 102 patients recruited into the study, two withdrew and re-assessment in five revealed 148 an actual NISS ≤15, leaving a study cohort of 95 patients ( Fig. 1A) . 149
Excluding eight fatalities and seven patients who had received steroid therapy, 80 survivors completed 150 sample collection over 6 months. To minimize confounders, we excluded the small groups of women (n=9) and 151 age-advanced men (n=11), leaving our final study cohort of 60 men <50 years of age ( Fig. 1B) . 152
A summary of the cohort characteristics is shown in Fig. 2 . Median age was 27 (interquartile range (IQR) 153 24-31) years, median NISS was 34 (IQR 29-44), and patient day-1 (=day of major trauma) APACHE II score was 154 21 (IQR 14-25). Patients remained ventilated on the intensive care unit (ICU) for a median of 9 (IQR 5-16) days. 155
Median length of hospital stay was 36 (IQR 19-56) days. Improvised Explosive Device (IED) (n=33; 55%) and 8 RTC (n=11; 18%) were the most common causes of injury. Twenty-five (42%) patients had at least one septic 157 episode and most occurred in the second week (Fig 2C) . 158
Glucocorticoid Biosynthesis and Metabolism After Major Trauma 159
Serum cortisol concentrations increased slightly after injury, peaking at 408 (IQR 249-511) nmol/L at two 160 weeks ( Fig. 3A; Suppl. Fig. 1A ) (34). However, concentrations remained within the wide range observed in 161 healthy controls. Serum concentrations of the inactive glucocorticoid metabolite cortisone were lower than normal 162 after injury, and increased slowly over time, but this trend was not significant (p=0·08) ( Fig. 3B; Suppl. Fig. 1B ) 163 (34). The serum cortisol-to-cortisone ratio, a marker of systemic 11β-HSD activities ( Fig. 3C) , peaked at two 164 weeks post-injury and returned to normal at around eight weeks. Consistent with these findings, urinary steroid 165 metabolite excretion analysis revealed an increase in glucocorticoid metabolite excretion in weeks 2, 4 and 8 after 166 major trauma, alongside changes in steroid metabolite ratios indicative of increased systemic 11β-HSD1 and 167 decreased 11β-HSD2 activities, as assessed by (5a-tetrahydrocortisol + tetrahydrocortisol)/tetrahydrocortisone 168 and cortisol-to-cortisone ratio, respectively (Suppl. Fig. 2+3 ) (34).
169
Androgen Biosynthesis and Activation After Major Trauma 170
Serum concentrations of the adrenal androgen precursor dehydroepiandrosterone (DHEA) were very low 171 after injury (p<0·0001, compared with healthy controls) but recovered to the normal range by three months post-172 injury ( Fig. 3D, Suppl. Fig. 1) (34) . In contrast, its sulfate ester, DHEAS, demonstrated sustained suppression; 173 median serum DHEAS concentrations did not recover to values within the healthy reference range, even at the end 174 of the 6-month study period ( Fig. 3E) . Consequently, the serum DHEA-to-DHEAS ratio (Fig. 3F ) increased by 175
week 2 compared with controls and failed to return to normal during the 6-month study period. The serum cortisol-176 to-DHEAS ratio ( Fig. 3G ) increased post-injury, peaking at 2 weeks, followed by a gradual decrease, but without 177 returning to normal by the end of the 6-month study period. 178
Serum concentrations of the androgen precursor androstenedione (Fig. 3H) were below the reference 179 range immediately after injury, recovering to the mid reference range at 2 weeks post-injury. Thus, serum 180 androstenedione concentrations recovered much faster than DHEA, suggestive of rapid downstream activation of 181
DHEA to androstenedione. 182
Serum testosterone (Fig. 3I, Suppl. Fig. 4A+B ) (34) was very low following injury, starting to increase 183 after two weeks, and recovering to the healthy sex-and age-matched reference range approximately eight weeks 184 after injury. This was mirrored by acute suppression of serum LH immediately after injury, followed by recovery 185 to the normal range approximately 2 weeks after injury (Suppl. as 5a-reductase is responsible for converting testosterone to the most potent androgen 5a-dihydrotestosterone. 196
Protein Catabolism After Major Trauma 197
The 24-hour total urinary nitrogen (TUN) excretion increased immediately after trauma, peaking at 198 25.0±16.1 g/day at the end of the first week, returning to below 15·0 g/day by week-4. The mean maximum rate 199 of nitrogen excretion was 33.0±21.3 g/day (Fig. 4A) . The normalization of TUN excretion coincided with the 200 gradual recovery of adrenal and gonadal androgen production ( Fig. 4B+C) . 201
The biceps brachii muscle was the most reliable site for ultrasound measurement of muscle thickness; 202 dressings, amputations and other wounds hampered the measurements of the other muscle areas. Changes in 203 biceps brachii muscle thickness followed a U-shaped curve after injury, reaching a nadir at 6 weeks (day-1 after 204 trauma compared with week-6, p=0·001). The mean muscle loss was 22.7±12.5% (Fig. 4D ). Similar to TUN, 205 muscle thickness recovered alongside gradually increasing adrenal and gonadal androgen production ( Fig. 4E+F) . 206
Clinical Course of Post-Traumatic Recovery and Serum Androgen Dynamics 207
The relationship between adrenal and gonadal androgens and the Sequential Organ Failure Score (SOFA) 208 and probability of sepsis are illustrated in Fig. 5 . During the first four weeks, serum DHEA, DHEAS, and 209 testosterone all correlated with the clinical SOFA score (autocorrelation factor (ACF) = 0·85, 0·90 and -0·79, 210 respectively). The serum concentrations of all three steroids also showed strong associations with the probability 211 of sepsis (R=-0·85, 0·85 and -0·97 for serum DHEA, DHEAS and testosterone, respectively). SOFA score and 212 probability of sepsis also correlated strongly with the DHEA:DHEAS ratio (autocorrelation factor (ACF) = -0·94 213 and -0·96 respectively) and with the serum cortisol-to-DHEAS ratio, negatively for the SOFA score but positively 214 for probability of sepsis (autocorrelation factor (ACF) = -0·81 and 0·89, respectively) (Suppl. Fig. 5 ) (34).
215
Opioid administration and endocrine recovery 216
To examine whether opioid administration affected endocrine recovery, we modelled the impact of the 217 total cumulative in-patient opioid dose on circulating steroid concentrations during recovery from major trauma. 218
For this purpose, we categorised patients according to cumulative opioid dose. Modelling took into account the 219 differences in ISS, length-of-stay (LOS), ICU LOS, and SOFA score. 220
The adjusted modelling revealed a dose-dependent impact of opioid treatment, with a higher initial peak 221 of serum cortisol and the cortisol/cortisone ratio in those on higher doses (≥3000mg) while those on lower doses 222 had initially lower serum cortisol concentrations but showed better recovery of cortisol and cortisol/cortisone 2 223 months into the recovery period, with broad interindividual variability in those with high cumulative opioid doses 224 ( Fig. 6) . 225
Opioid administration showed a pronounced, dose-dependent effect on adrenal and gonadal androgen 226 production, with significantly delayed recovery of serum DHEA and DHEAS in patients on higher opioid doses 227 (p=0.029, p=<0.001 respectively; Fig. 7) . By contrast, serum testosterone concentrations, which were initially 228 equally suppressed in all cumulative dose groups, showed a much faster recovery in individuals who received 229 higher (≥3000mg) total cumulative opioid doses. However, these confidence intervals were large for these model 230 estimates (Fig. 7) . 231
DISCUSSION 232
In this study, we have characterized the response of adrenal and gonadal steroids and catabolic metabolism 233 to severe injury, describing the related dynamic changes for six months post-injury. Modelling the data has 234 allowed us to provide a detailed description of the transition from catabolism to anabolism during recovery from 235 severe injury, including investigating the impact of cumulative in-patient opioid dose. Our data are the first to 236 provide detailed adrenal and gonadal steroids beyond the first days after trauma in a large cohort of young patients, 237 with all patients recruited prospectively and steroid analysis carried out by tandem mass spectrometry. 238
As summarized in a recent meta-analysis (35), previous data on serum cortisol after injury are limited to 239 small cohorts derived from elective surgery, rarely followed up for more than two days. In our study, serum 240 cortisol quickly returned to normal following slight initial increases after acute trauma. In contrast, serum 241 cortisone remained low for three months post-injury. Our study revealed an initial phase of minor glucocorticoid 242 activation with a transient increase in the serum cortisol-to-cortisone ratio, with changes in urinary glucocorticoid 243 metabolites indicative of increased 11β-HSD1 activity. The cortisol-activating enzyme 11β-HSD1 is the major 244 enzyme converting inactive cortisone to cortisol and has been shown to be upregulated systemically and locally in 245 response to inflammation, thereby dampening the inflammatory response (36,37). Skeletal muscle expresses 11β-246 HSD1 (38), Previous studies reported increased 11β-HSD1 activity in an animal model of trauma haemorrhage 247 (39). and improved wound healing in mice treated with 11β-HSD1 inhibitors (40). However, human data after 248 trauma are lacking. There is substantial evidence indicating a reduced cortisol clearance in critical illness, due to 249 decreased cortisol inactivation in liver and kidney (41), this mechanism could also be responsible for the slight 250 changes in cortisol and cortisone we observed. This was corroborated by the observed reduction in the urinary 251 cortisol-to-cortisone ratio, which is reflective of 11β-HSD2 activity. 252
Interestingly, patients on higher opioid doses, showed a higher early peak in cortisol production after 253 trauma, followed by persistently lower circulating cortisol during the recovery period, as compared with patients 254 on lower opioid doses. Previous reports have described suppressive effects of opioids on the HPA axis, though 255 studies in smaller mammals have indicated an acute stimulatory effect of opioid administration on serum cortisol 256 concentrations (42,43).
12
We observed a pronounced and sustained loss of adrenal and gonadal androgen synthesis within the first 258 24 hours following acute major trauma. The recovery of circulating DHEA and testosterone concentrations took 259 two and four months post-injury, respectively, and DHEAS remained pathologically suppressed at the end of the 260 six-month follow-up period. In a mouse model of acute inflammation, sustained suppression of the expression of 261 the DHEA sulfotransferase SULT2A1 and its sulfate donor enzyme, PAPSS2, have been described (44). We 262 reviewed 23 previous studies that measured serum DHEA and DHEAS in critically ill patients (Suppl . Table 1 ) 263 (45), but most studies followed patients for only a few days and relatively few patients suffered from acute trauma. 264
One previous study measured both serum DHEA and DHEAS in 181 patients with septic shock, and 31 patients 265 with acute hip fracture (46). Serum DHEAS was decreased in both groups, while DHEA was increased in sepsis 266 but decreased after trauma. This suggested an inflammation-mediated downregulation of DHEA sulfation after 267 trauma, resulting in a dissociation of serum DHEA and DHEAS. In our study, this was also observed, as indicated 268 by a sustained increase in the serum DHEA/DHEAS ratio and persistently low serum DHEAS concentrations. 269
A number of previous studies have described an association of infection and mortality with low circulating 270 DHEAS concentrations and a raised serum cortisol-to-DHEAS ratio in patients with trauma (47-50). In vitro 271 studies have demonstrated that cortisol decreases neutrophil superoxide production, which is counteracted by 272 coincubation with DHEAS (47). Furthermore, we have previously shown that DHEAS, but not DHEA, directly 273 enhances neutrophil superoxide generation; a key mechanism of human bactericidal function via activation of 274 protein kinase C-β, independent of androgen receptor signalling (51). In the present study, carried out in severely 275 injured men younger than 50 years of age, we observed suppression of both serum DHEA and DHEAS post-injury, 276
indicating that the loss of adrenal androgen synthesis is a trauma-related event. Importantly, we showed for the 277 first time that this decrease in circulating adrenal androgen precursors is sustained for several months, and that 278
DHEAS remains low even six months post-injury. 279
Alongside the decrease in adrenal androgen synthesis, we observed a near complete loss of gonadal 280 testosterone production and pituitary LH secretion immediately after trauma. Both the gradual recovery of adrenal 281 and gonadal androgen production paralleled the decrease in catabolism, as assessed by urinary nitrogen excretion 282 and biceps muscle thickness. The suppression of the hypothalamus-pituitary-gonadal (HPG) axis after severe 283 13 injury shown in our study is supported by the literature (52-55). Our prospective, longitudinal data demonstrate 284 that suppression of the HPG axis is of shorter duration than that of the HPA axis. In traumatic brain injury studies, 285 a significant proportion of patients go on to develop anterior pituitary dysfunction including secondary 286 hypogonadism (56). However, in our study traumatic brain injury was an exclusion criterion. While limited data 287 from patients with burns and critical illness have suggested a central, hypothalamic-pituitary cause of trauma-288 related hypogonadism (57,58), the evidence prior to our study has been limited. Our data indicated a central cause 289 of suppression to the gonadotrophic axis, with a decrease in both pituitary LH and gonadal testosterone. 290
Interestingly, we observed a differential impact of the cumulative opioid dose on adrenal and gonadal androgens, 291 respectively, with a significantly delayed recovery of DHEA and DHEAS, but a trend towards faster recovery of 292 gonadal testosterone synthesis in patients with higher cumulative opioid doses. Previous data on opioid effects on 293 adrenal androgen production are very scarce, but our findings with respect to gonadal testosterone biosynthesis 294 contrasted previous studies describing suppressive opioid effects on the HPG axis (42,43).
295
Our study revealed a loss of both adrenal and gonadal androgen production in young and middle-aged 296 men after major trauma. This effect was further enhanced by long-lasting suppression of androgen-activating 297 systemic 5a-reductase activity, as demonstrated by urinary steroid metabolite analysis. Androgens are important 298 in wound healing, erythrocytosis, bone density and muscle mass (59). The catabolic state that occurs following 299 trauma thus presents a significant challenge. The use of androgens to ameliorate catabolism has some precedent, 300 as evidenced by the use of the synthetic androgen, oxandrolone, that has some proven benefit in treating burn 301 injury (10) . A meta-analysis of 15 Randomised Controlled Trials including 806 burns patients by Li et al, showed 302 significant benefits (P < 0.05) for using oxandrolone, including less net weight loss, lean body mass loss, nitrogen 303 loss, donor-site healing time, and length of stay in the catabolic and rehabilitative phases (60). The use of 304 oxandrolone in major trauma was investigated in two intensive care studies but no benefit was demonstrated 305 (61,62).
306
The strengths of our study include its prospective nature, narrow age range of the patients, single 307 gender, single site for recruitment and analysis and detailed follow-up over six months as well as the 308 measurement of circulating (and in a smaller cohort also excreted) steroid hormones by state-of-the-art 309 14 mass spectrometry assays. Analysing a young to middle-aged patient cohort has also reduced the 310 confounding effects of age-related co-morbidities. Another strength is the unique opportunity our study 311 offered for analysis of the opioid effects on endocrine recovery, facilitated by detailed prospective, 312 longitudinal phenotyping with dedicated software.
313
Our study was limited by the diverse nature of major trauma patients in relation to injury pattern and the 314 involvement of military casualties. The timing and number of observations during our study was pragmatic and 315 some statistical comparisons were made using modelled data. While we measured total cortisol and cortisone by 316 tandem mass spectrometry, we did not measure free cortisol or cortisol-binding globulin. We were only able to 317 measure urinary steroid excretion in a sub-cohort of patients, as accurate and repeated collection of 24-h urine 318 proved very challenging under ICU conditions. The estimation of nitrogen excretion was pragmatic due to the 319 diverse nature of the patients and we were not able to record nitrogen intake. Ultrasound estimation of muscle 320 thickness was performed at four different body sites, but many individuals had limbs missing or extensive wounds 321 that prevented measurements. While imperfect, the longitudinal nature of these measurements allowed us to model 322 these changes over time. 323
In conclusion, in this most detailed and first prospective study of the steroid response to major trauma, we 324 followed the patients from severe injury to six months of recovery, revealing pronounced and sustained decreases 325 in adrenal and gonadal androgen biosynthesis. Recovery of androgen production in the severely injured patients 326 was mirrored by a switch from catabolism to anabolism as reflected by recovery of muscle mass and a decrease in 327 nitrogen loss. Adrenal and gonadal androgens correlated with risk of sepsis. It is tempting to suggest that an 328 anabolic intervention with androgens or androgen precursors could have a beneficial effect on health outcomes 329 during recovery from major trauma. However, this will need to be investigated by future intervention studies. Data are represented after modelling of the raw data (Suppl. Fig. 1 ) using a non-linear mixed effects model that 532 accounts for unbalanced repeated measures using a 4-knot cubic spline. Modelled data are shown as means and 533 95% confidence intervals. 534 days 1-7-14-28, of the burned at 1-7-14-28-56, as well as after 6 and 12 months.
All androgens (T, DHT, FT) decreased significantly in the males, DHEAS decreased in male and females. 
